Clinical Oncology
Volume 21, Issue 8 , Pages 634-635 , October 2009

Trastuzumab-induced Radiation Recall Dermatitis — First Reported Case

  • R.K. Shrimali

      Affiliations

    • Department of Clinical Oncology, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN, UK
  • ,
  • N.J. McPhail

      Affiliations

    • Department of Clinical Oncology, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN, UK
  • ,
  • P.D. Correa

      Affiliations

    • Department of Clinical Oncology, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN, UK
  • ,
  • J. Fraser

      Affiliations

    • Department of Medical Oncology, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN, UK
  • ,
  • M. Rizwanullah

      Affiliations

    • Department of Clinical Oncology, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN, UK

References 

  1. Common Toxicity Criteria, CTC Version 2.0. National Cancer Institute publications. 9. 30 April 1999;
  2. D'Angio GJ, Farber S, Maddock CL. Potentiation of X-ray effects of actinomycin D. Radiology. 1959;73:175–177
  3. Jeter MD, Janne PA, Brooks S, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002;53:394–400
  4. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59:237–245
  5. Azria D, Magne N, Zouhair A, et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev. 2005;31:555–570
  6. Camidge DR, Kunkler IH. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence. Clin Oncol. 2000;12:272–273

PII: S0936-6555(09)00106-X

doi: 10.1016/j.clon.2009.03.003

Clinical Oncology
Volume 21, Issue 8 , Pages 634-635 , October 2009